General Info
Location: 235 East 42nd Street
Country: United States of America
Industries: Rare Disease, Internal Medicine, Inflammation & Immunology, Vaccines, Oncology, Anti Infectives, Platform Technologies, Diagnostics, Drug Delivery, Pharmaceutical Services
Investment Regions:
Investment Stages: seed, series-a
corporate-vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a PRNewswire press release dated Oct 15, 2025 showing Pfizer Venture Investments (Pfizer Ventures) as a backer of Mission Therapeutics. Also found an Oct 2, 2025 BusinessWire item showing Pfizer Ventures led a financing for Cartography on Oct 2, 2025. Both investments are within one month of the target date, indicating last known investments less than 3 months prior. The startup mentioned: Mission Therapeutics (and Cartography). The recency (Oct 2025) places the investor in the highest activity category.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Barbara …
Senior Managing Partner
Christopher …
Principal
Denis …
Managing Partner
Laszlo …
Principal
Michael …
Principal
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Pfizer Ventures
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI